Published online Nov 26, 2014. doi: 10.4330/wjc.v6.i11.1209
Revised: August 27, 2014
Accepted: September 16, 2014
Published online: November 26, 2014
Processing time: 338 Days and 13.7 Hours
Both diabetes mellitus and hyperglycemia per se are associated with negative outcomes after cardiac surgery. In this article, we review these associations, the possible mechanisms that lead to adverse outcomes, and the epidemiology of diabetes focusing on those patients requiring cardiac surgery. We also examine outpatient and perioperative management of diabetes with the same focus. Finally, we discuss our own efforts to improve glycemic management of patients undergoing cardiac surgery at our institution, including keys to success, results of implementation, and patient safety concerns.
Core tip: There is a growing body of evidence that moderate glycemic control (e.g., 120-180 mg/dL, 6.7-10.0 mmol/L) is an appropriate goal in cardiac surgery. Achieving this goal can be accomplished by adopting a multidisciplinary approach, addressing the entire continuum of care, demanding a short project timeline, and identifying gaps in current management.